Small RNA fingerprinting of Alzheimer’s disease frontal cortex extracellular vesicles and their comparison with peripheral extracellular vesicles

ABSTRACT Alzheimer’s disease is a progressive neurodegenerative disorder, with the strongest disease-associated changes observed at clinical or end-stage disease. Transcriptomic deregulation of miRNA expression can spread via “horizontal” RNA transfer through extracellular vesicles (EVs) to act in conjunction with proteins, leading to changes in mRNA, which can provide early signals to indicate forthcoming neuropathological changes in the brain. Here, we analysed the small RNA content, in particular, miRNA, contained in brain-derived EVs isolated from the frontal cortex of Alzheimer’s subjects (n = 8) and neurological control subjects (n = 9). Brain-derived EVs were found to contain an upregulation of disease-associated miRNA. RNA species from brain-derived EVs were correlated with miRNA profiles obtained from matching total brain homogenate. These results provide a blueprint into the biological pathways potentially effected during disease that may be assisted by brain-derived EV RNA horizontal transfer.We also correlated the miRNA changes in the brain with those detected in peripheral EVs collected from serum of Alzheimer’s disease patients (n = 23, and healthy controls, n = 23) and revealed a panel of miRNA that could be used as a liquid brain biopsy. Overall, our study provides the first interrogation of the small RNA contents in brain-derived EVs and how they could be used to understand the early pathological changes in Alzheimer’s disease which will benefit the development of an early diagnostic blood test.

[1]  Hans-Peter Lenhof,et al.  miRPathDB 2.0: a novel release of the miRNA Pathway Dictionary Database , 2019, Nucleic Acids Res..

[2]  Manolis Kellis,et al.  Single-cell transcriptomic analysis of Alzheimer’s disease , 2019, Nature.

[3]  Dylan T Burnette,et al.  Reassessment of Exosome Composition , 2019, Cell.

[4]  F. Guerini,et al.  SNAP-25 in Serum Is Carried by Exosomes of Neuronal Origin and Is a Potential Biomarker of Alzheimer’s Disease , 2019, Molecular Neurobiology.

[5]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[6]  Bin Zhang,et al.  Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer’s disease susceptibility , 2018, Nature Genetics.

[7]  Seong-Min Cho,et al.  Exosomal secretion of truncated cytosolic lysyl-tRNA synthetase induces inflammation during cell starvation , 2018, Cell stress.

[8]  Nela Durisic,et al.  Exosomes taken up by neurons hijack the endosomal pathway to spread to interconnected neurons , 2018, Acta Neuropathologica Communications.

[9]  J. Lötvall,et al.  Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins , 2018, Cellular and Molecular Life Sciences.

[10]  C. Masters,et al.  A rigorous method to enrich for exosomes from brain tissue , 2017, Journal of extracellular vesicles.

[11]  Pilhan Kim,et al.  Caspase-8 controls the secretion of inflammatory lysyl-tRNA synthetase in exosomes from cancer cells , 2017, The Journal of cell biology.

[12]  E. Goetzl,et al.  Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes , 2017, Front. Neurosci..

[13]  Anja Schneider,et al.  The release and trans-synaptic transmission of Tau via exosomes , 2017, Molecular Neurodegeneration.

[14]  Lesley Cheng,et al.  Defining the purity of exosomes required for diagnostic profiling of small RNA suitable for biomarker discovery , 2016, RNA biology.

[15]  M. Alonso,et al.  DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients , 2016, Oncotarget.

[16]  E. Goetzl,et al.  Cargo proteins of plasma astrocyte‐derived exosomes in Alzheimer's disease , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Marcela Dávila López,et al.  Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells – Evidence of unique microRNA cargos , 2015, RNA biology.

[18]  R. Petersen,et al.  Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study , 2015, Alzheimer's & Dementia.

[19]  R. Petersen,et al.  Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer's disease , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  Juha E. Jääskeläinen,et al.  Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models , 2015, Neurobiology of Aging.

[21]  C. Rowe,et al.  Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment , 2014, Molecular Psychiatry.

[22]  Suresh B. Mudunuri,et al.  Meta-analysis of tRNA derived RNA fragments reveals that they are evolutionarily conserved and associate with AGO proteins to recognize specific RNA targets , 2014, BMC Biology.

[23]  M. Verbeek,et al.  MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid , 2014, Neurobiology of Aging.

[24]  Andrew F. Hill,et al.  Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles , 2014, Journal of extracellular vesicles.

[25]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[26]  C. Rowe,et al.  The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease , 2009, International Psychogeriatrics.

[27]  C. Masters,et al.  Inhibition of γ‐secretase causes increased secretion of amyloid precursor protein C‐terminal fragments in association with exosomes , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  Andrew King,et al.  Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium , 2008, Brain pathology.

[29]  A. Roses,et al.  Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways , 2008 .

[30]  R. Cappai,et al.  Packaging of prions into exosomes is associated with a novel pathway of PrP processing , 2007, The Journal of pathology.

[31]  W. Lukiw,et al.  Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus , 2007, Neuroreport.

[32]  P. Verkade,et al.  Alzheimer's disease beta-amyloid peptides are released in association with exosomes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Stähelin.  Guidelines , 1994, Communicating Science.

[34]  Quaid Morris,et al.  Probing microRNAs with microarrays: tissue specificity and functional inference. , 2004, RNA.

[35]  W. Faigle,et al.  Cells release prions in association with exosomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.